Intraoperative cholangiography use during cholecystectomy does not reduce the incidence of common hepatic duct or common bile duct injuries.
Intraoperative cholangiography is not effective in preventing common duct injuries during cholecystectomy, according to a study published in The Journal of the American Medical Association.
In an effort to reduce injuries to the common hepatic duct or common bile duct that remain in the 0.3 percent to 0.5 percent range during cholecystectomy, investigators from the University of Texas sought to evaluate the usefulness of intraoperative cholangiography.
The retrospective study identified 92,932 Medicare beneficiaries from 307 hospitals in Texas, ages 66 years or older, who underwent inpatient or outpatient cholecystectomy for biliary colic or biliary dyskinesia, acute cholecystitis, or chronic cholecystitis between 2001 and 2009. There were a total of 37,533 cholecystectomies with intraoperative colangiography (40.4 percent) and 55,399 without (59.6 percent).
The researchers found the common duct injury rate was 0.21 percent (79 injuries) among the patients with intraoperative cholangiography and 0.36 percent (201 injuries) among patients without it.
"In a logistic regression model controlling for patient, surgeon, and hospital characteristics, the odds of common duct injury for cholecystectomies performed without intraoperative cholangiography were increased compared with those performed with it,” the authors wrote. “When confounding was controlled with instrumental variable analysis, the association between cholecystectomy performed without intraoperative cholangiography and duct injury was no longer significant."
The authors concluded, based on these results, “[r]outine intraoperative cholangiography should not be advocated as means for preventing common duct injury.”
Can AI Facilitate Improved Dual-Energy X-Ray Screening for Patients at High Risk of Osteoporosis?
June 28th 2024Out of 315 patients identified by artificial intelligence (AI) as being at high risk for osteoporosis, subsequent screening with dual-energy X-ray absorptiometry (DXA) in a randomized controlled trial revealed new-onset osteoporosis in 237 patients.
FDA Clears Mobile C-Arm Device Designed for Complex Vascular Procedures
June 17th 2024Offering a combination of intuitive user-friendly controls and enhanced imaging, the Zenition 90 Motorized C-arm reportedly facilitates workflow efficiencies and bolsters visualization for complex vascular procedures, cardiac interventions, and other clinical procedures.
Qure.ai to Debut Multimodality AI Platform for Lung Cancer Imaging at ASCO 2024
May 29th 2024In addition to detecting missed lung nodules on X-rays, the AI-powered Qure.ai lung cancer continuum platform reportedly automates lung nodule measurement on CT scans and facilitates multimodality reporting.